Oncology PracticeFDA approves olaparib for certain metastatic prostate cancersMay 21, 2020Genitourinary CancerProstate CancerOncology
Oncology PracticeFDA expands approval of atezolizumab in NSCLCMay 20, 2020Lung CancerMixed TopicsOncology
Oncology PracticeFirst PARP inhibitor approved for metastatic prostate cancerMay 19, 2020Genitourinary CancerProstate CancerOncology
Oncology PracticeFDA approves ripretinib for advanced GISTsMay 18, 2020GastroenterologyGastrointestinal Cancer
Oncology PracticeFDA approves pomalidomide for Kaposi sarcomaMay 15, 2020Sarcoma & GISTHIVNonmelanoma Skin CancerGI Oncology
Hematology NewsCOVID-19 fears tied to dangerous drop in child vaccinationsMay 14, 2020COVID-19 UpdatesPediatricsVaccinesInfectious DiseasesPulmonologySurgery
Oncology PracticeFDA approves selpercatinib for lung and thyroid RET tumorsMay 11, 2020Lung CancerHead & Neck/Thyroid Cancers
Oncology PracticeOperation Quack Hack: FDA moves to stop fraudulent COVID-19 productsMay 8, 2020COVID-19 UpdatesBusiness of MedicineInfectious DiseasesPractice Management
Hematology NewsFDA grants EUA to muscle stimulator to reduce mechanical ventilator usageMay 5, 2020COVID-19 UpdatesHealth PolicyInfectious Diseases
Oncology PracticeFDA tightens requirements for COVID-19 antibody testsMay 4, 2020COVID-19 UpdatesPractice ManagementBusiness of MedicineHealth PolicyInfectious Diseases
Oncology PracticeFDA OKs new drug for triple-negative breast cancerApril 23, 2020Breast CancerMetastatic Breast CancerWomen's HealthOncology